A detailed history of Stephens Consulting, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Stephens Consulting, LLC holds 258 shares of DXCM stock, worth $14,979. This represents 0.01% of its overall portfolio holdings.

Number of Shares
258
Previous 250 3.2%
Holding current value
$14,979
Previous $16.8 Million 1.79%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 13, 2026

BUY
$54.84 - $71.06 $438 - $568
8 Added 3.2%
258 $17.1 Million
Q3 2025

Oct 15, 2025

SELL
$66.46 - $89.53 $797 - $1,074
-12 Reduced 4.58%
250 $16.8 Million
Q2 2025

Jul 25, 2025

BUY
$59.83 - $87.57 $15,675 - $22,943
262 New
262 $22.9 Million
Q1 2022

Jan 19, 2023

SELL
$94.08 - $130.2 $658 - $911
-7 Closed
0 $0
Q4 2021

Jan 19, 2023

BUY
$129.87 - $162.82 $909 - $1,139
7 New
7 $3.76 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Stephens Consulting, LLC Portfolio

Follow Stephens Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.